Orbiva and Articura Sign MOU for Healthcare AI in Indonesia
Orbiva, a wholly owned subsidiary of Home Control International, signed a strategic cooperation MOU with Indonesia based Articura on July 23, 2026, the companies announced in a press release. At the signing ceremony, Orbiva also introduced products tailored for the Articura project.
The companies plan to work on healthcare AI infrastructure and digital health solutions for Indonesia. The scope includes healthcare AI reasoning rule systems, healthcare data and knowledge systems for hospitals and clinics, home healthcare, remote monitoring, digital health records, and AI use in hospital settings.
Planned hospital functions include AI enabled consultation before visits, patient triage, clinical decision support, medical record quality control, patient follow up, and tools for hospital operations. Orbiva will contribute AI, AIoT smart device, healthcare data processing, and edge computing technology, while Articura will provide healthcare deployment experience, hospital system integration, and local hospital networks.
Articura also plans to establish a National AI Healthcare Lab for demonstrations, model validation, research, and professional education. Representatives from Indonesia's Ministry of Health and Ministry of Communication and Digital Affairs attended the signing ceremony.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Sep 11 Evergreen Digital Media Invests in Adwave and Licenses AI Ad Platform Sep 11 Rime to Power Dialpad Voice AI Products Sep 11 Ultima Genomics and NVIDIA Collaborate on Pangenome Sequencing Analysis Sep 11 Zettabyte and Raku Plan Renewable Energy AI Data Centers in Asia Sep 11 DCM Services and AKUVO Partner on Estate RecoveryMore from Life Sciences
Sep 12 Aignostics Opens Early Access to PathoSearch Sep 11 Ultima Genomics and NVIDIA Collaborate on Pangenome Sequencing Analysis Sep 11 UrgentIQ Raises $15 Million for AI Clinical Workflows Sep 11 Penguin Ai Launches Revenue Cycle AI Platform Sep 11 MegazoneCloud Builds Quality Assurance AI Agent for Hanmi PharmaceuticalLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Arintra Raises $25 Million for Healthcare Revenue Assurance AI
TransformativeMed and Red Rover Health Partner on Agentic AI for Oracle Health EHR
HiRO and Differentia Biotech Sign MOU for AI Clinical Trial Simulation
Atman Health Wins ARPA-H Award to Build Heart Failure AI
ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
Daily AI Brief: the AI news that matters, in your inbox.